Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just been granted a new patent for its innovative Mont-Blanc MIS range in the Europe.
Since 2008, Spineway has invested in industrial property, enabling it to display a portfolio of more than 35 patents and confirm its status as an innovative company. In line with its strategy of strengthening its higher value-added product lines, Spineway pursues its sustained intellectual property policy, which results in the regular filing of new patents.
After the United States, the European Patent Office (EPO) has just awarded Spineway a patent for its Mont-Blanc MIS range, granting it a monopoly of exploitation and the protection of its innovation in nearly 40 countries for a period of 20 years. This recognition confirms the innovative nature of its MIS range, marking an important step for its redeployment. With this patent, which strengthens the Group’s portfolio, Spineway will continue its innovation strategy and strengthen its positions in mature countries.